Desq Long
Sign in

Company

Arbutus Biopharma Corp

ABUS · CIK 0001447028

SEC FORM 4
$168,105.60

Arbutus Biopharma Corp (ABUS)

Acquisition (code M) of 52,533 shares at $3.20 per share.

Reporting Person Beardsley Robert A · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000050 · filed 2026-09-23 · View filing →

SEC FORM 4
$334,112.00

Arbutus Biopharma Corp (ABUS)

Acquisition (code M) of 78,800 shares at $4.24 per share.

Reporting Person Beardsley Robert A · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000050 · filed 2026-09-23 · View filing →

SEC FORM 4
$502,218.99

Arbutus Biopharma Corp (ABUS)

Disposition (code F) of 99,057 shares at $5.07 per share.

Reporting Person Beardsley Robert A · Transaction Code F

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000050 · filed 2026-09-23 · View filing →

SEC FORM 4
$175,460.22

Arbutus Biopharma Corp (ABUS)

Acquisition (code M) of 52,533 shares at $3.34 per share.

Reporting Person Sawhney Roger · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000051 · filed 2026-09-23 · View filing →

SEC FORM 4
$334,112.00

Arbutus Biopharma Corp (ABUS)

Acquisition (code M) of 78,800 shares at $4.24 per share.

Reporting Person Sawhney Roger · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000051 · filed 2026-09-23 · View filing →

SEC FORM 4
$509,575.56

Arbutus Biopharma Corp (ABUS)

Disposition (code F) of 100,508 shares at $5.07 per share.

Reporting Person Sawhney Roger · Transaction Code F

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000051 · filed 2026-09-23 · View filing →

SEC FORM 4
$927,031.25

Arbutus Biopharma Corp (ABUS)

Acquisition (code M) of 265,625 shares at $3.49 per share.

Reporting Person Nguyen Tuan · Officer Title Chief Financial Officer · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000052 · filed 2026-09-23 · View filing →

SEC FORM 4
$120,615.25

Arbutus Biopharma Corp (ABUS)

Acquisition (code M) of 27,475 shares at $4.39 per share.

Reporting Person Nguyen Tuan · Officer Title Chief Financial Officer · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000052 · filed 2026-09-23 · View filing →

SEC FORM 4
$1,047,649.59

Arbutus Biopharma Corp (ABUS)

Disposition (code F) of 206,637 shares at $5.07 per share.

Reporting Person Nguyen Tuan · Officer Title Chief Financial Officer · Transaction Code F

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000052 · filed 2026-09-23 · View filing →

SEC FORM 4
$372,505.60

Arbutus Biopharma Corp (ABUS)

Acquisition (code M) of 116,408 shares at $3.20 per share.

Reporting Person Androski Lindsay · Officer Title President and CEO · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000053 · filed 2026-09-23 · View filing →

SEC FORM 4
$45,901.84

Arbutus Biopharma Corp (ABUS)

Acquisition (code M) of 10,456 shares at $4.39 per share.

Reporting Person Androski Lindsay · Officer Title President and CEO · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000053 · filed 2026-09-23 · View filing →

SEC FORM 4
$418,411.89

Arbutus Biopharma Corp (ABUS)

Disposition (code F) of 82,527 shares at $5.07 per share.

Reporting Person Androski Lindsay · Officer Title President and CEO · Transaction Code F

Traded Sep 18, 2026 · Disclosed Sep 23, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001447028-26-000053 · filed 2026-09-23 · View filing →